A 5-day: the favourable way?

Ann Hematol. 2014 Sep;93(9):1619-20. doi: 10.1007/s00277-013-2005-9. Epub 2014 Jan 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Azacitidine / administration & dosage*
  • Female
  • Humans
  • Male
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / mortality*

Substances

  • Azacitidine